UofL believes it's made breakthrough in COVID-19 treatment, works to fast-track approval

They explained it this way: The technology is based on a piece of synthetic DNA, or an “aptamer,” which targets and binds with a human protein called nucleolin. Researchers said early tests show this aptamer may stop viruses, including novel coronavirus, from “hijacking” nucleolin to replicate inside the body.WLKYNews